Biotechnology Assets, S.A. (BST:041)
Germany · Delayed Price · Currency is EUR 0.4450
-0.0030 (-0.67%)
At close: Jul 24, 2025
Biotechnology Assets Revenue
In the year 2024, Biotechnology Assets had annual revenue of 2.97M EUR, down -24.13%. Biotechnology Assets had revenue of 1.86M in the half year ending December 31, 2024, with 3.34% growth.
Revenue
2.97M
Revenue Growth
-24.13%
P/S Ratio
8.26
Revenue / Employee
87.21K
Employees
34
Market Cap
24.49M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.97M | -943.29K | -24.13% |
| Dec 31, 2023 | 3.91M | 950.58K | 32.14% |
| Dec 31, 2022 | 2.96M | -324.07K | -9.87% |
| Dec 31, 2021 | 3.28M | 390.31K | 13.50% |
| Dec 31, 2020 | 2.89M | -345.59K | -10.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.89B |
| Siemens Aktiengesellschaft | 77.82B |
| Deutsche Telekom AG | 120.25B |
| Allianz SE | 109.03B |
| Rheinmetall AG | 10.48B |
| Siemens Energy AG | 37.44B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
| Deutsche Bank Aktiengesellschaft | 29.24B |